Outset Medical (OM) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.94, -3.43% vs the prior close of $4.08.
- Volume 68.53K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OM slides 3.4% to $3.94. Closed at $3.94, -3.43% vs the prior close of $4.08. Day range $3.90–$4.22, opened at $4.09.
OM daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — OM slides 3.4% to $3.94
- Closed at $3.94, -3.43% vs the prior close of $4.08. Day range $3.90–$4.22, opened at $4.09.
- Volume was 68.53K shares, 0.4x its 50-day average of 168.20K — lighter than usual.
- Price is +3.5% vs its 50-day average ($3.81) and -5.5% vs its 200-day average ($4.17).
- 52-week range $2.84–$15.94; today's close sits at 8% of that range, 75.3% below the 52-week high.
Oct 15, 2026 — OM jumps 6.3% to $4.08
- Closed at $4.08, +6.25% vs the prior close of $3.84. Day range $3.80–$4.11, opened at $3.85.
- Volume was 54.60K shares, 0.3x its 50-day average of 169.02K — lighter than usual.
- Price is +6.5% vs its 50-day average ($3.83) and -2.1% vs its 200-day average ($4.17).
- 52-week range $2.84–$15.94; today's close sits at 9% of that range, 74.4% below the 52-week high.
Oct 14, 2026 — OM slides 5.4% to $3.84
- Closed at $3.84, -5.42% vs the prior close of $4.06. Day range $3.82–$4.01, opened at $4.01.
- Volume was 80.00K shares, 0.5x its 50-day average of 169.83K — lighter than usual.
- Price is -0.3% vs its 50-day average ($3.85) and -7.8% vs its 200-day average ($4.17).
- 52-week range $2.84–$15.94; today's close sits at 8% of that range, 75.9% below the 52-week high.
Oct 13, 2026 — OM rises 1.2% to $4.06
- Closed at $4.06, +1.25% vs the prior close of $4.01. Day range $3.96–$4.14, opened at $3.99.
- Volume was 68.00K shares, 0.4x its 50-day average of 170.32K — lighter than usual.
- Price is +4.7% vs its 50-day average ($3.88) and -2.5% vs its 200-day average ($4.16).
- 52-week range $2.84–$15.94; today's close sits at 9% of that range, 74.5% below the 52-week high.
Oct 12, 2026 — OM dips 1.0% to $4.01, 3 down days in a row
- Closed at $4.01, -0.99% vs the prior close of $4.05. Day range $4.00–$4.11, opened at $4.08.
- Volume was 66.30K shares, 0.4x its 50-day average of 170.46K — lighter than usual.
- Price is +2.9% vs its 50-day average ($3.90) and -3.6% vs its 200-day average ($4.16).
- 52-week range $2.84–$15.94; today's close sits at 9% of that range, 74.8% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — OM dips 1.0% to $4.05
- Closed at $4.05, -0.98% vs the prior close of $4.09. Day range $4.02–$4.27, opened at $4.15.
- Volume was 72.80K shares, 0.4x its 50-day average of 170.00K — lighter than usual.
- Price is +3.6% vs its 50-day average ($3.91) and -2.6% vs its 200-day average ($4.16).
- 52-week range $2.84–$16.16; today's close sits at 9% of that range, 74.9% below the 52-week high.
Oct 8, 2026 — OM dips 2.9% to $4.09
- Closed at $4.09, -2.85% vs the prior close of $4.21. Day range $4.03–$4.26, opened at $4.12.
- Volume was 241.00K shares, 1.4x its 50-day average of 166.42K.
- Price is +4.3% vs its 50-day average ($3.92) and -1.6% vs its 200-day average ($4.15).
- 52-week range $2.84–$16.16; today's close sits at 9% of that range, 74.7% below the 52-week high.
Oct 7, 2026 — OM rises 1.7% to $4.21, a 1-month high, 5 up days in a row
- Closed at $4.21, +1.69% vs the prior close of $4.14. Day range $4.06–$4.25, opened at $4.06.
- Volume was 135.00K shares, 0.8x its 50-day average of 167.31K.
- Price is +7.0% vs its 50-day average ($3.93) and +1.4% vs its 200-day average ($4.15).
- 52-week range $2.84–$16.16; today's close sits at 10% of that range, 73.9% below the 52-week high.
- That makes 5 straight gains.
Oct 6, 2026 — OM rises 1.0% to $4.14, a 1-month high on 2.3x normal volume
- Closed at $4.14, +0.98% vs the prior close of $4.10. Day range $4.05–$4.34, opened at $4.29.
- Volume was 376.60K shares, 2.3x its 50-day average of 161.18K — unusually heavy trading.
- Price is +4.9% vs its 50-day average ($3.94) and -0.2% vs its 200-day average ($4.15).
- 52-week range $2.84–$16.16; today's close sits at 10% of that range, 74.4% below the 52-week high.
- That makes 4 straight gains.
Oct 5, 2026 — OM jumps 3.5% to $4.10, a 1-month high, 3 up days in a row
- Closed at $4.10, +3.54% vs the prior close of $3.96. Day range $3.85–$4.16, opened at $3.96.
- Volume was 203.10K shares, 1.3x its 50-day average of 158.90K.
- Price is +3.8% vs its 50-day average ($3.95) and -1.2% vs its 200-day average ($4.15).
- 52-week range $2.84–$16.16; today's close sits at 9% of that range, 74.6% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — OM jumps 5.6% to $3.96, a 1-month high on 3.2x normal volume
- Closed at $3.96, +5.60% vs the prior close of $3.75. Day range $3.54–$4.09, opened at $3.77.
- Volume was 483.70K shares, 3.2x its 50-day average of 152.32K — unusually heavy trading.
- Price is +0.3% vs its 50-day average ($3.95) and -4.5% vs its 200-day average ($4.15).
- 52-week range $2.84–$16.16; today's close sits at 8% of that range, 75.5% below the 52-week high.
OM latest news & SEC filings
Every SEC filing by or about OM in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Leonard Braden Michael bought 228,334 shares at $3.53 (≈$806.02K) on Oct 1, 2026; now holds 2,748,035
- Leonard Braden Michael bought 16,575 shares at $3.88 (≈$64.24K) on Oct 2, 2026; now holds 2,764,610
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Trigg Leslie sold 3,437 shares at $4.39 (≈$15.09K) on Aug 17, 2026
- Trigg Leslie sold 3,437 shares at $4.39 (≈$15.09K) on Aug 17, 2026
- Trigg Leslie sold 3,437 shares at $4.39 (≈$15.09K) on Aug 17, 2026
- Trigg Leslie sold 3,437 shares at $4.39 (≈$15.09K) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brottem John L. sold 2,632 shares at $4.39 (≈$11.55K) on Aug 17, 2026
- Brottem John L. sold 2,632 shares at $4.39 (≈$11.55K) on Aug 17, 2026
- Brottem John L. sold 2,632 shares at $4.39 (≈$11.55K) on Aug 17, 2026
- Brottem John L. sold 2,632 shares at $4.39 (≈$11.55K) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gaeta Renee sold 4,543 shares at $4.39 (≈$19.94K) on Aug 17, 2026
- Gaeta Renee sold 4,543 shares at $4.39 (≈$19.94K) on Aug 17, 2026
- Gaeta Renee sold 4,543 shares at $4.39 (≈$19.94K) on Aug 17, 2026
- Gaeta Renee sold 4,543 shares at $4.39 (≈$19.94K) on Aug 17, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 14, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 12, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $31.64M (prior year $31.42M) (+0.7% vs Jun 30, 2025)
- Net income: -$17.98M (prior year -$18.54M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.97 (prior year -$1.04) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade OM
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: Jun 17, 2026, May 7, 2026, Feb 11, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 4.03% (largest 25.0%). That is a volatile stock.
- Liquidity: about 199.26K shares (≈$785.09K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.94 vs a range of $2.84–$15.94 (8% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:15 on Mar 20, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Leslie Trigg sold 3,437 shares on Aug 17, 2026.
- Latest filings: 8-K Aug 28, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 18.80M shares outstanding (Aug 4, 2026), +5.8% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Electromedical & Electrotherapeutic Apparatus.
OM market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.09 | 4.22 | 3.90 | 3.94 | 68.53K |
| Oct 15, 2026 | 3.85 | 4.11 | 3.80 | 4.08 | 54.60K |
| Oct 14, 2026 | 4.01 | 4.01 | 3.82 | 3.84 | 80.00K |
| Oct 13, 2026 | 3.99 | 4.14 | 3.96 | 4.06 | 68.00K |
| Oct 12, 2026 | 4.08 | 4.11 | 4.00 | 4.01 | 66.30K |
| Oct 9, 2026 | 4.15 | 4.27 | 4.02 | 4.05 | 72.80K |
| Oct 8, 2026 | 4.12 | 4.26 | 4.03 | 4.09 | 241.00K |
| Oct 7, 2026 | 4.06 | 4.25 | 4.06 | 4.21 | 135.00K |
| Oct 6, 2026 | 4.29 | 4.34 | 4.05 | 4.14 | 376.60K |
| Oct 5, 2026 | 3.96 | 4.16 | 3.85 | 4.10 | 203.10K |
| Oct 2, 2026 | 3.77 | 4.09 | 3.54 | 3.96 | 483.70K |
| Oct 1, 2026 | 3.07 | 3.89 | 2.86 | 3.75 | 980.30K |
| Sep 30, 2026 | 3.04 | 3.09 | 2.98 | 3.00 | 92.50K |
| Sep 29, 2026 | 2.96 | 3.05 | 2.90 | 3.03 | 123.40K |
| Sep 28, 2026 | 3.04 | 3.04 | 2.84 | 2.96 | 186.30K |
| Sep 25, 2026 | 3.13 | 3.30 | 3.04 | 3.05 | 169.00K |
| Sep 24, 2026 | 3.13 | 3.18 | 3.05 | 3.13 | 234.00K |
| Sep 23, 2026 | 3.25 | 3.25 | 3.09 | 3.09 | 76.80K |
| Sep 22, 2026 | 3.15 | 3.31 | 3.13 | 3.29 | 152.90K |
| Sep 21, 2026 | 3.17 | 3.21 | 3.10 | 3.12 | 120.40K |
About Outset Medical
Outset Medical (OM) is listed on the Nasdaq and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in SAN JOSE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1484612.
OM board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Karen Drexler | Director | Jun 5, 2026 |
| D Keith Grossman | Director | Jun 5, 2026 |
| Patrick T Hackett | Director | Jun 5, 2026 |
| Brent D. Lang | Director | Jun 5, 2026 |
| Kevin C Oboyle | Director | Jun 5, 2026 |
| Karen Prange | Director | Jun 5, 2026 |
| Leslie Trigg | Chair and CEO | Aug 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John L. Brottem | General Counsel | Aug 18, 2026 |
| Derick A. Elliott | EVP, Commercial | Apr 8, 2026 |
| Renee Gaeta | Chief Financial Officer | Aug 18, 2026 |
| Marc Nash | EVP Operations R&D & Service | May 19, 2026 |
| Leslie Trigg | Chair and CEO | Aug 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Leslie Trigg | Sale | 3,437 | $4.39 |
| Aug 17, 2026 | Leslie Trigg | Sale | 3,437 | $4.39 |
| Aug 17, 2026 | Leslie Trigg | Sale | 3,437 | $4.39 |
| Aug 17, 2026 | Leslie Trigg | Sale | 3,437 | $4.39 |
| Aug 17, 2026 | Renee Gaeta | Sale | 4,543 | $4.39 |
| Aug 17, 2026 | Renee Gaeta | Sale | 4,543 | $4.39 |
| Aug 17, 2026 | Renee Gaeta | Sale | 4,543 | $4.39 |
| Aug 17, 2026 | Renee Gaeta | Sale | 4,543 | $4.39 |
| Aug 17, 2026 | John L. Brottem | Sale | 2,632 | $4.39 |
| Aug 17, 2026 | John L. Brottem | Sale | 2,632 | $4.39 |
| Aug 17, 2026 | John L. Brottem | Sale | 2,632 | $4.39 |
| Aug 17, 2026 | John L. Brottem | Sale | 2,632 | $4.39 |
| Jun 3, 2026 | Renee Gaeta | Sale | 17,672 | $4.94 |
| Jun 3, 2026 | Renee Gaeta | Sale | 17,672 | $4.94 |
| Jun 3, 2026 | Renee Gaeta | Sale | 17,672 | $4.94 |
OM financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $119.48M | $-81.65M | -5.37 | $-46.33M |
| Dec 31, 2024 | $113.69M | $-127.98M | -36.96 | $-116.30M |
| Dec 31, 2023 | $130.38M | $-172.80M | -52.28 | $-131.37M |
| Dec 31, 2022 | $115.38M | $-162.96M | -3.38 | $-145.73M |
| Dec 31, 2021 | $102.60M | $-131.94M | -2.89 | $-130.26M |
Latest balance sheet: total assets $242.38M, total liabilities $146.05M, cash $35.01M (as of Jun 30, 2026).
OM earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $5.20 |
| Jun 17, 2026 | 8-K Item 2.02 (results) | $4.02 |
| May 7, 2026 | 8-K Item 2.02 (results) | $4.68 |
| Feb 11, 2026 | 8-K Item 2.02 (results) | $4.54 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $5.57 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $12.07 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $13.17 |
| May 7, 2025 | 8-K Item 2.02 (results) | $11.74 |
| Feb 19, 2025 | 8-K Item 2.02 (results) | $14.10 |
| Jan 6, 2025 | 8-K Item 2.02 (results) | $19.05 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $9.30 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)Integer (ITGR)TransMedics (TMDX)Axogen (AXGN)LivaNova (LIVN)Nexalin Technology (NXL)Conmed (CNMD)Ceribell (CBLL)InMode (INMD)Electromed (ELMD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on OM
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.